Authors: PICKAR JH THORNEYCROFT I WHITEHEAD M

Citation: Jh. Pickar et al., EFFECTS OF HORMONE REPLACEMENT THERAPY ON THE ENDOMETRIUM AND LIPID PARAMETERS - A REVIEW OF RANDOMIZED CLINICAL-TRIALS, 1985 TO 1995, American journal of obstetrics and gynecology, 178(5), 1998, pp. 1087-1099

Authors: PICKAR JH ARCHER DF

Citation: Jh. Pickar et Df. Archer, IS BLEEDING A PREDICTOR OF ENDOMETRIAL HYPERPLASIA IN POSTMENOPAUSAL WOMEN RECEIVING HORMONE REPLACEMENT THERAPY, American journal of obstetrics and gynecology, 177(5), 1997, pp. 1178-1183

Authors: WOODRUFF JD PICKAR JH

Citation: Jd. Woodruff et Jh. Pickar, RISK OF ENDOMETRIAL HYPERPLASIA PROGRESSING TO CANCER - REPLY, American journal of obstetrics and gynecology, 172(4), 1995, pp. 1320-1320

Authors: LOBO RA PICKAR JH WILD RA WALSH B HIRVONEN E

Citation: Ra. Lobo et al., METABOLIC IMPACT OF ADDING MEDROXYPROGESTERONE ACETATE TO CONJUGATED ESTROGEN THERAPY IN POSTMENOPAUSAL WOMEN, Obstetrics and gynecology, 84(6), 1994, pp. 987-995

Authors: ARCHER DF PICKAR JH BOTTIGLIONI F

Citation: Df. Archer et al., BLEEDING PATTERNS IN POSTMENOPAUSAL WOMEN TAKING CONTINUOUS COMBINED OR SEQUENTIAL REGIMENS OF CONJUGATED ESTROGENS WITH MEDROXYPROGESTERONE ACETATE, Obstetrics and gynecology, 83(5), 1994, pp. 686-692

Authors: WOODRUFF JD PICKAR JH

Citation: Jd. Woodruff et Jh. Pickar, INCIDENCE OF ENDOMETRIAL HYPERPLASIA IN POSTMENOPAUSAL WOMEN TAKING CONJUGATED ESTROGENS (PREMARIN) WITH MEDROXYPROGESTERONE ACETATE OR CONJUGATED ESTROGENS ALONE, American journal of obstetrics and gynecology, 170(5), 1994, pp. 1213-1223